Oncocyte Corporation

NASDAQ:OCX   3:59:50 PM EDT
2.26
-0.06 (-2.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)208.43M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.28 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$2.59
50-Day MA$3.29
200-Day MA$4.50
See more pivots

Oncocyte Corporation Stock, NASDAQ:OCX

15 Cushing, Suite 102, Irvine, California 92618
United States of America
Phone: +1.949.409.7600
Number of Employees: 51

Description

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.